Adjunctive Use of Direct Thrombin Inhibitors in Patients Receiving Fibrinolytic Therapy for Acute Myocardial Infarction

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.2, 2004-01, pp. : 107-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjunctive Therapy for Percutaneous Revascularization in Acute Myocardial Infarction

Current Pharmaceutical Design, Vol. 10, Iss. 4, 2004-02 ,pp. : 399-405

Bentham Science Publishers

Access to resources Recommend Favorite

Optimizing Reperfusion Therapy: Adjunct Use of Glycoprotein IIb/IIIa Antagonists with Fibrinolytic Therapy in Acute Myocardial Infarction

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 52-55

Karger

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Tenecteplase in Fibrinolytic Therapy of Acute Myocardial Infarction

By Tanswell P.

Clinical Pharmacokinetics, Vol. 41, Iss. 15, 2002-01 ,pp. : 1229-1245

Adis International

Access to resources Recommend Favorite

New Approaches to Treatment of Acute Myocardial Infarction: Combination Antiplatelet and Fibrinolytic Therapy

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 192-200

Karger

Access to resources Recommend Favorite

Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction

Heart Drug, Vol. 1, Iss. 2, 2004-11 ,pp. : 71-76

Karger

Access to resources Recommend Favorite